Cargando...

Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma

Sunitinib is associated with a robust objective response rate in patients with metastatic clear cell renal cell carcinoma (RCC). The primary objective of this phase II clinical trial was to assess the overall response rate for sunitinib in patients with papillary metastatic RCC as well as other non-...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Molina, Ana M., Feldman, Darren R., Ginsberg, Michelle S., Kroog, Glenn, Tickoo, Satish K., Jia, Xiaoyu, Georges, Murielle, Patil, Sujata, Baum, Michael S., Reuter, Victor E., Motzer, Robert J.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2010
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3257373/
https://ncbi.nlm.nih.gov/pubmed/20711632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-010-9491-6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!